Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1053)	2/25/1998 1:03:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 2742

I just talked with Hal Smith. He could not explain the discrepancy between the 22,983,687 in the 12/15 release and the outstanding shares as listed in today's release. He will talk to Galton and get back to me. I clearly expressed my anger over Galton's attempt to make the company appear unattractive. My best guess is that they're trying to shake shares out of Grausz. My relationship with Galton/Smith has become very antagonistic. I will only get the basics. There were (and are!) clear paths to success at CIST, paths that rely on innovation and science rather than the transfer of discounted shares from one pocket to another.